Newbridge Financial Services Group’s Tandem Diabetes Care TNDM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.3K	Hold	120	–	–	﹤0.01%	1006
2025 Q4	$2.64K	Sell	120 -200	-63%	-$3.61K	﹤0.01%	990
2025 Q3	$3.88K	Hold	320	–	–	﹤0.01%	1065
2025 Q2	$5.96K	Hold	320	–	–	﹤0.01%	998
2025 Q1	$6.13K	Sell	320 -240	-43%	-$7.02K	﹤0.01%	764
2024 Q4	$20.2K	Buy	+560	New	+$18.9K	0.01%	597
2024 Q3	–	Sell	-630	Closed	-$25.4K	–	1077
2024 Q2	$25.4K	Sell	630 -475	-43%	-$19.8K	0.01%	526
2024 Q1	$39.1K	Sell	1,105 -3,365	-75%	-$90.2K	0.02%	442
2023 Q4	$132K	Sell	4,470 -1,555	-26%	-$32.3K	0.06%	238
2023 Q3	$125K	Buy	6,025 +2,615	+77%	+$71.8K	0.06%	255
2023 Q2	$83.7K	Buy	3,410 +1,500	+79%	+$48.3K	0.04%	346
2023 Q1	$77.6K	Buy	1,910 +500	+35%	+$20.7K	0.04%	363
2022 Q4	$63.4K	Buy	1,410 +700	+99%	+$31.7K	0.04%	403
2022 Q3	$34K	Sell	710 -41	-5%	-$2.25K	0.02%	560
2022 Q2	$44K	Hold	751	–	–	0.03%	434
2022 Q1	$87K	Sell	751 -3,429	-82%	-$400K	0.04%	337
2021 Q4	$629K	Sell	4,180 -280	-6%	-$37.8K	0.3%	73
2021 Q3	$532K	Buy	4,460 +110	+3%	+$12.1K	0.33%	68
2021 Q2	$424K	Sell	4,350 -6,926	-61%	-$618K	0.26%	90
2021 Q1	$995K	Buy	11,276 +110	+1%	+$10.2K	0.73%	18
2020 Q4	$1.07M	Buy	11,166 +221	+2%	+$22.8K	0.88%	13
2020 Q3	$1.24M	Buy	+10,945	New	+$1.15M	1.22%	7